Multi-drug resistant Mycobacterium leprae from patients with leprosy

Japanese Journal of Leprosy

Volumn 73, Issue 3, 2004, Pages 227-233

  Maeda, Shinji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti leprous chemotherapy; Drug resistance; Genetic diagnosis; Leprosy; Point mutation

Indexed keywords

CLOFAZIMINE; DAPSONE; ISONIAZID; NEW DRUG; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SPARFLOXACIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIUM ISOLATE; DNA SEQUENCE; FOLP GENE; GENE MUTATION; GYRA GENE; LEPROSY; MULTIDRUG RESISTANCE; MYCOBACTERIUM LEPRAE; NONHUMAN; REVIEW; RPOB GENE;

EID: 11144328861     PISSN: 13423681     EISSN: None     Source Type: Journal    
DOI: 10.5025/hansen.73.227     Document Type: Review

References (15)

1. Espinal, MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S, Rieder HL, Binkin N, Dye C, Williams R, Raviglione MC : Global trends in resistance to antituberculosis drugs. World Health Organization- International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 344:1294-1303, 2001.
2. Gillespie SH: Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob Agents Chemother 46:267-274, 2002.
3. Shepard CC: A kinetic method for the study of drugs against Mycobacterium leprae in mice. Int J Lepr Other Mycobact Dis 35:429-435, 1967.
4. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, Matter L, Schopfer K, Bodmer T: Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650, 1993.
5. Jamal MA, Maeda S, Nakata N, Kai M, Fukuchi K, Kashiwabara Y: Molecular basis of clarithromycin-resistance in Mycobacterium avium-intracellulare complex. Tuber Lung Dis 80:1-4, 2000.
6. Pettit JHS, Rees RJW: Sulphone resistance in leprosy. An experimental and clinical study. Lancet 2:673-674, 1964.
7. Jacobson RR, Hastings RC: Rifampin-resistant leprosy. Lancet 2:1304-1305, 1976.
8. Ji B, Perani EG, Petinom C, Grosset JH: Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. Antimicrob Agents Chemother 40:393-399, 1996.
9. Takiff HE, Salazar L, Guerrero C, Philipp W, Huang WM, Kreiswirth B, Cole ST, Jacobs WR Jr, Telenti A: Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 38:773-780, 1994.
10. Honore N, Cole ST: Molecular basis of rifampin resistance in Mycobacterium leprae. Antimicrob Agents Chemother 37:414-418, 1993.
11. Vedantam G, Guay GG, Austria NE, Doktor SZ, Nichols BP: Characterization of mutations contributing to sulfathiazole resistance in Escherichia coli. Antimicrob Agents Chemother 42:88-93, 1998.
12. Ramaswamy S, Musser JM: Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79:3-29, 1998.
13. Kai M, Matsuoka M, Nakata N, Maeda S, Gidoh M, Maeda Y, Hashimoto K, Kobayashi K, Kashiwabara Y: Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene. FEMS Microbiol Lett 177:231-235, 1999.
14. Cambau E, Perani E, Guillemin I, Jamet P, Ji B: Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae. Lancet 349:103-104, 1997.
15. http://www.who.int/lep/Reports/s20042.pdf